Cancer Decision Support Tool - Bradford District and Craven

This is to support the NHS Long Term Plan that sets two objectives for improving cancer outcomes

and will build on the progress already made through delivery of the recommendations of the

Independent Cancer Taskforce (2015).

The award of the contract will assist in the achievement of 75% early diagnosis target by 2028/29.

This will be achieved as the tool promotes improved decision making which will:

• Improve the quality of 2 week wait referrals enabling reduced delays in cancer diagnostic pathways
• Increase appropriate direct access diagnostic uptake
• Improves primary care safety netting procedures
• Delivers the ambition of significant improvement in the proportion of cancers diagnosed at stage 1 and 2.

The commissioners undertook a thorough options analysis to define market offerings against

Bradford place requirements. The outcome of which concluded that the C the Signs solution offered

and best financial value and functionality in line with the long-term plan and PCN DES 2021/22

service requirements. This included but is not limited to full integration to primary care systems

(SystmOne) with the added benefit of a tracking process for all tests in line with PCN DES and QOF

requirements.

The system has a self-audit function to ensure that data is input correctly and appropriately. Real

time data is available for pathways and fully automated process means that there will be fewer

errors which will lead to a better use of practice resources.

The contract award will be for a period of three years at an annualised contract value of circa

£137,472 (total contract value £413,472). The services are deemed to be subject to the full

regime of current procurement legislation and governed by the Public Contracts Regulations

2015. The Commissioner will voluntarily advertise this notice of intention to award this contract to

reach as wide an audience as possible and to promote transparency and in line with regulation

32(2)(b)(ii). The Commissioner is firmly of the view that competition is absent for technical

reasons, and that the organisation listed above is the only provider capable of meeting the CCG's

needs with its intuitive and proactive systems functionality which is linked to the long-term plan

and PCN DES 2021/22 service requirement.

Funding is through the Cancer alliance and will be through bidding on yearly basis. If funding is

not made available in future years then contact termination will be triggered.